World Immunotherapy Congress 2018
29th - 31st October 2018, Basel, Switzerland
Discover. Develop. Bring to market. For biotech, pharma and their partners.
Our vision is to bring together the full community and provide a single meeting point for the whole value chain. It is where science meets business to make immunotherapy the cornerstone of the fight against cancer.
For the third instalment of the World Immunotherapy Congress, we have introduced more content allowing us to delve deeper into the case studies, clinical trials and immunotherapy discovery than ever before.
With two full tracks of content over the three days, covering oncology, non-oncology (infectious disease, inflammation, autoimmune disorders, organ transplant and neurological disease), oncolytics, cancer vaccines, safety, and efficacy, we are covering all bases.
As part of the Festival of Biologics, the World Immunotherapy Congress will be co-located with World Biosimilar Congress, European Antibody Congress and HPAPI World Congress. Attendees will have access to plenty of content across the 3 days and more networking opportunities than ever before with over 800+ leading industry professionals.